Inquiry

* Please note that all of our services and products are intended for preclinical research use only and cannot be used to diagnose, treat or manage patients.

Anti-MI/R injury agent 1

Cat. No.: IBDI-432838

Anti-MI/R injury agent 1 (compound 18), a Panaxatriol derivative, is an orally active, potent anti-myocardial ischemia/reperfusion (anti-MI/R) injury agent. Anti-MI/R injury agent 1 enhances oxygen-glucose deprivation and reperfusion (OGD/R)-induced cardiomyocyte injury cell viability. Anti-MI/R injury agent 1 can markedly reduce myocardial infarction size, decrease circulating cardiac troponin I (cTnI) leakage, and alleviate cardiac tissue damage in the rats.

Size (Solid):

Product Details

Target Others
Molecular Weight 543.73
SMILES CC1(C)C2=C(C(C(O)=O)=NO2)C[[email protected]@]3(C)C1[[email protected]@H](O)C[[email protected]]4(C)C3C[[email protected]@H](O)C5[[email protected]@]4(C)CC[[email protected]]5([H])[[email protected]@]6(C)CCCC(C)(C)O6

Storage & Handling

Shipping Room temperature in continental US. May vary elsewhere.
Storage Please store the product under the recommended conditions in the Certificate of Analysis.
Regulatory Status This product is for RESEARCH USE ONLY and is not intended for therapeutic or diagnostic use.
! For research use only, not intended for any clinical use.